Abbott’s HIV drug, kaletra, faces pre grant opposition in India, Europe

Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis

TIME

Save America’s Patent System

The New York Times

The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.

Filter

Abbott’s HIV drug, kaletra, faces pre grant opposition in India, Europe

Abbott Lab’s bid for anti-HIV drug patent to face stiff challenge

Booster shot: US body opposes Abbott’s patent in India, Europe

I-MAK Challenges Patents on Lifesaving HIV Drug Combination in Europe, India

I-MAK Announces: BigPatents India Revolutionizes Indian Patent System

I-MAK speaks to the New Scientist about innovation

Learn more about how you can help build a more equitable system for all